 |
Ben Butkus is senior editor of GenomeWeb's premium content and the editor of PCR Insider. He covers technologies and trends in PCR, qPCR, nucleic acid amplification, and sample prep. E-mail Ben Butkus or follow his GenomeWeb Twitter account at @PCRInsider. |
Qiagen Q4, 2012 Growth Driven Significantly by QiaSymphony Sales in MDx, Applied Markets
January 31, 2013
Qiagen Q4, 2012 Growth Driven Significantly by QiaSymphony Sales in MDx, Applied Markets
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Qiagen Plans Mid-Year Launch of Clinical NGS Platform; Says Gene Panels will Complement RT-PCR Tests
January 9, 2013 / Clinical Sequencing News - Dx Focus: Clarient to Offer Qiagen Therascreen KRAS Test as Erbitux CDx
January 31, 2013 / PCR Insider - Dx Focus: Cepheid Xpert CT/NG; Qiagen Therascreen EGFR; Luminex xTag GPP; Hologic Aptima Trichomonas
January 17, 2013 / PCR Insider - Qiagen Submits EGFR Companion Dx to FDA
January 15, 2013 / GenomeWeb Daily News - Qiagen Looks to IMDx to Accelerate Test Menu Development for QiaSymphony RGQ Platform
January 10, 2013 / PCR Insider